Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18356628 | 0.91 | USP2 (0.48) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL14024388 | 0.91 | USP2 (0.48) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL13016489 | 0.85 | USP2 (0.43) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL20679022 | 0.83 | USP2 (0.57) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL17933584 | 0.83 | USP2 (0.41) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL3248547 | 0.82 | TSHR (0.71) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL6582696 | 0.81 | — | — | |
| Ethane Dimethane Sulfonate SCHEMBL1336145 | 0.78 | USP2 (0.75) | USP2TSHRKDM4EALDH1A1LMNA | |
| SCHEMBL1957438 | 0.74 | USP2 (0.46) | USP2TSHRKDM4EALDH1A1LMNA | |
| Ethane Dimethane Sulfonate SCHEMBL4149477 | 0.73 | USP2 (0.67) | USP2TSHRKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534435-B2 | Lipids and nanoparticle compositions thereof | GENERATION BIO CO. (US) | 2026-01-27 | — | — | US | disclosed |
| EP-2952541-B1 | RUBBER COMPOSITION, AND PNEUMATIC TIRE USING SAME | BRIDGESTONE CORP (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250361208-A1 | LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF | GENERATION BIO CO (US) | 2025-11-27 | — | — | US | disclosed |
| US-12252470-B2 | Lipids and nanoparticle compositions thereof | GENERATION BIO CO. (US) | 2025-03-18 | — | — | US | disclosed |
| EP-4452942-A1 | NANOMATERIALS COMPRISING DISULFIDES | Beam Therapeutics Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| US-20240335542-A1 | NANOMATERIALS COMPRISING DISULFIDES | BEAM THERAPEUTICS INC. | 2024-10-10 | — | — | US | disclosed |
| US-20240294474-A1 | NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF | GENERATION BIO CO. | 2024-09-05 | — | — | US | disclosed |
| US-20230320993-A1 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | GENERATION BIO CO. | 2023-10-12 | — | — | US | disclosed |
| US-20230320993-A1 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | GENERATION BIO CO. | 2023-10-12 | — | — | US | disclosed |
| WO-2023121964-A1 | NANOMATERIALS COMPRISING DISULFIDES | BEAM THERAPEUTICS INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2007110540-A2 | DYEING COMPOSITION CONTAINING A THIOL/DISULPHIDE FLUORESCENT COLORANT COMPRISING AN ALKOXY/HYDROXY GROUPING, WITH AN INTERNAL CATIONIC CHARGE, AND METHOD FOR LIGHTENING KERATIN MATERIALS USING SAID COLORANT | L'OREAL (FR) | 2007-10-04 | — | — | WO | disclosed |
| US-20060080791-A1 | Dyeing composition comprising at least one disulphide dye and method of dyeing human keratin fibers using this dye | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | disclosed |
| EP-1647580-A1 | Dying composition comprising a particular disulfide dye and process of dying keratinous fibres with this dye. | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| US-6825187-B2 | CARBAPENEM DERIVATIVES SUBSTITUTED AT THE 2-POSITION WITH A SUBSTITUTED IMIDAZO(5,1-B)THIAZOLE GROUP; USE AGAINST ANTIBIOTIC RESISTANT STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA, ENTEROCOCCI AND INFLUENZA VIRUS | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| EP-1251133-B1 | NOVEL CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-6680313-B2 | 1-HYDROXYETHYL-2(IMIDAZO(5,1B)THIAZOL-2-YL-1-CARBAPEN-2-EM-3-C CARBOXYLIC ACID OR SALT, EXCELLENT ANTIBIOTIC ACTIVITY AGAINST A WIDE SPECTRUM OF BACTERIA | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-01-20 | — | — | US | disclosed |
| US-20030027809-A1 | Novel carbapenum derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| US-20030022881-A1 | Novel carbapenem derivatives of quarternary salt type | MEIJI SEIKA KAISHA, LTD. (JP) | 2003-01-30 | — | — | US | disclosed |
| EP-1251134-A1 | NOVEL CARBAPENEM DERIVATIVES OF QUATERNARY SALT TYPE | MEIJI SEIKA KAISHA LTD. (JP) | 2002-10-23 | — | — | EP | disclosed |
| EP-1251133-A1 | NOVEL CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA LTD. (JP) | 2002-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534435-B2 | Lipids and nanoparticle compositions thereof | AGO2, NSUN3, POLRMT | USP2 1577/4885TSHR 2912/4885KDM4E 1788/4885 |
| US-20030027809-A1 | Novel carbapenum derivatives | DHPS, DPEP1, OXA1L | USP2 1717/4885TSHR 4709/4885KDM4E 720/4885 |
| US-20240335542-A1 | NANOMATERIALS COMPRISING DISULFIDES | GPX4, GPX1, ABCB7 | USP2 1221/4885TSHR 3231/4885KDM4E 4498/4885 |
| US-20060080791-A1 | Dyeing composition comprising at least one disulphide dye and method of dyeing human keratin fibers using this dye | KRT18, DSG1, DSC1 | USP2 1489/4885TSHR 4553/4885KDM4E 1490/4885 |
| US-20240294474-A1 | NOVEL LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF | LIPG, NPC1L1, NPC1 | USP2 3452/4885TSHR 3721/4885KDM4E 3836/4885 |
| US-20230320993-A1 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | POLN, POLRMT, LIPG | USP2 2100/4885TSHR 4566/4885KDM4E 3851/4885 |
| US-12252470-B2 | Lipids and nanoparticle compositions thereof | LIPG, NPC1L1, NPC1 | USP2 3815/4885TSHR 3809/4885KDM4E 3966/4885 |
| US-20250361208-A1 | LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF | LIPG, NPC1L1, NPC1 | USP2 3815/4885TSHR 3809/4885KDM4E 3966/4885 |
| US-20030022881-A1 | Novel carbapenem derivatives of quarternary salt type | DHPS, HDHD5, RRP15 | USP2 1667/4885TSHR 4206/4885KDM4E 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.